|
시장보고서
상품코드
2084748
아목시실린 시장 : 제형별, 용도별, 유통 채널별, 지역별Amoxicillin Market, By Dosage Form, By Application, By Distribution Channel, By Geography |
||||||
아목시실린 시장은 2026년에 58억 4,000만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 82억 7,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 5.1%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 58억 4,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 5.10% | 2033년 시장 규모 예측 : | 82억 7,000만 달러 |
아목시실린 시장은 제약 업계에서 중요한 부문입니다. 이는 아목시실린이 호흡기 감염증, 요로 감염증, 피부 감염증, 치과 감염증 및 기타 세균성 질환의 치료에 널리 처방되어 왔기 때문입니다. 광역 스펙트럼 페니실린계 항생제인 아목시실린은 전 세계에서 가장 널리 사용되는 항생제이며, 그 확실한 효능과 안전성으로 인해 WHO의 필수 의약품 리스트에도 등재되어 있습니다.
신흥 국가에서 세균성 감염증 발생률이 증가하고, 의료 서비스 접근성이 향상되며, 의약품 생산 능력이 확대됨에 따라 이 시장은 성장세를 보이고 있습니다. 성인 및 소아 부문 모두를 아우르는 정제, 캡슐, 경구 현탁액, 주사제 등의 제형이 주요 제품 부문을 구성하고 있습니다. 저렴한 가격과 구하기 쉬운 점 덕분에 제네릭 아목시실린 제품의 수요가 대부분을 차지하고 있지만, 효능을 향상시키고 환자의 복약 순응도를 높이기 위해 각 제약사는 개량형 제제 및 병용 요법의 개발에 힘쓰고 있습니다.
시장 역학
전 세계 아목시실린 시장은 주로 호흡기, 요로, 피부, 치과 감염증을 비롯한 다양한 세균 감염증의 유병률 증가에 힘입어 성장하고 있으며, 이에 따라 효과적인 항생제에 대한 수요가 지속적으로 이어지고 있습니다. 신흥 국가에서의 의료 서비스 접근성 확대, 제약 생산 능력 강화, 의료비 증가가 시장 성장을 지원하고 있습니다. 감염병에 걸리기 쉬운 고령 인구의 증가 역시 시장 성장을 더욱 촉진하고 있습니다.
그러나 시장에는 항생제 내성 증가, 항생제 적정 사용 프로그램 확대, 신약 및 새로운 항생제 제제와의 경쟁 심화 등 몇 가지 제약 요인이 존재합니다. 그럼에도 불구하고 새로운 아목시실린 복합제의 개발, 아직 충분히 공략되지 않은 의료 시장의 개발, 그리고 비용 대비 효과가 높은 제네릭 항생제에 대한 수요 확대에는 큰 시장 기회가 숨어 있습니다. 아목시실린 시장의 지속적인 성장은 제형 개선과 환자의 복약 순응도 강화, 그리고 필수 의약품의 접근성 확대를 위한 노력의 강화에 힘입어 이루어지고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 아목시실린 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 아목시실린 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 아목시실린 시장을 분석하는 데 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 아목시실린 시장 : 제형별, 2021-2033년
제5장 세계의 아목시실린 시장 : 용도별, 2021-2033년
제6장 세계의 아목시실린 시장 : 유통 채널별, 2021-2033년
제7장 세계의 아목시실린 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
KSA 26.07.14Amoxicillin Market is estimated to be valued at USD 5.84 Bn in 2026 and is expected to reach USD 8.27 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.84 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.10% | 2033 Value Projection: | USD 8.27 Bn |
The amoxicillin market is an important segment of the pharmaceutical industry, as amoxicillin has been widely prescribed in the treatment for respiratory tract infections, urinary tract infections, skin infections, dental infections, and other bacterial diseases. Being a broad-spectrum penicillin antibiotic, amoxicillin is the most extensively used antibiotic all over the world and has also been added to the WHO List of Essential Medicines owing to its assured efficacy and safety.
The market is gaining momentum through the increasing incidence of bacterial infections, rising access to health care services and growing pharmaceutical manufacturing capacity in emerging economies. Tablet, capsules, oral suspension and injectable dosage forms that cater to both adult and pediatric segment form the major product segments. Though the demand for generic amoxicillin products constitutes a larger part due to its low price and large availability, the development of enhanced forms and combination therapies is being undertaken by manufacturers for increased efficacy and patient compliance.
Market Dynamics
The global amoxicillin market is driven by the escalating prevalence of various bacterial infections, predominantly respiratory, urinary tract, skin and dental infections, leading to continued demand for effective antibiotics. Growing access to healthcare, expansion of pharmaceutical manufacturing capacities and rising health expenditure in emerging countries fuel market growth. Rising elderly population susceptible to infectious diseases further stimulate market growth.
However, a number of constraints are present in the market, such as rise in antimicrobial resistance, rise in the number of antibiotic stewardship programs and increase in competition with novel drugs and antibiotic formulations. Nevertheless, significant market opportunities lie in formulation of new amoxicillin combinations, exploration of health care markets which are still not adequately covered and growing the demand for cost-effective generic antibiotics. Sustained growth of the amoxicillin market is supported by increasing efforts towards enhancing the formulation and increasing patient compliance and expanding availability of essential drugs.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global amoxicillin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Sandoz Group AG, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited,Sun Pharmaceutical Industries Ltd., Cipla Limited, Lupin Limited, Amneal Pharmaceuticals, Inc., Viatris Inc., Hikma Pharmaceuticals PLC, and Dr. Reddy's Laboratories Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global amoxicillin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global amoxicillin market
Market Segmentation
- Dosage Form Insights (Revenue, USD Bn, 2021 - 2033)
- Tablets and Capsules
- Oral Suspensions
- Injectable Formulations
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Respiratory Tract Infections
- Urinary Tract Infections
- Skin and Soft Tissue Infections
- Ear, Nose and Throat Infections
- Others
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Sandoz Group AG
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma Limited
- Sun Pharmaceutical Industries Ltd.
- Cipla Limited
- Lupin Limited
- Amneal Pharmaceuticals, Inc.
- Viatris Inc.
- Hikma Pharmaceuticals PLC
- Reddy's Laboratories Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Amoxicillin Market, By Dosage Form
- Global Amoxicillin Market, By Application
- Global Amoxicillin Market, By Distribution Channel
- Global Amoxicillin Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global Amoxicillin Market, By Dosage Form, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Tablets and Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Oral Suspensions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Injectable Formulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Amoxicillin Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Respiratory Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Skin and Soft Tissue Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ear, Nose and Throat Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Amoxicillin Market, By Distribution Channel, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Amoxicillin Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Sandoz Group AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aurobindo Pharma Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cipla Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lupin Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amneal Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reddy's Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
